Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.77 NOK | +10.06% | +11.64% | -93.67% |
Apr. 17 | Ultimovacs to Reduce 40% of Workforce Amid Operational Adjustments | MT |
Apr. 17 | Transcript : Ultimovacs ASA - Special Call |
Business Summary
Number of employees: 26
Managers
Managers | Title | Age | Since |
---|---|---|---|
Carlos de Sousa
CEO | Chief Executive Officer | 66 | 20-05-31 |
Director of Finance/CFO | 57 | - | |
Chief Tech/Sci/R&D Officer | - | - | |
Jens Bjørheim
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Øivind Foss
CTO | Chief Tech/Sci/R&D Officer | - | - |
Audun Tornes
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anne Hovi Worsøe
IRC | Investor Relations Contact | 60 | 21-09-30 |
Mc Callion Orla
LAW | General Counsel | - | 21-09-30 |
Gudrun Trøite
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jónas Einarsson
CHM | Chairman | 67 | 11-01-25 |
Henrik Schüssler
BRD | Director/Board Member | 61 | 14-12-31 |
Kari Grønås
BRD | Director/Board Member | 59 | 18-12-31 |
Haakon Stenrod
BRD | Director/Board Member | 44 | 20-11-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 34,406,061 | 23,730,397 ( 68.97 %) | 0 | 68.97 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-93.67% | 22.41M | |
+22.11% | 47.9B | |
+46.56% | 41.42B | |
-2.45% | 40.7B | |
-6.20% | 28.92B | |
+10.68% | 25.55B | |
-21.06% | 19.27B | |
-1.70% | 12.15B | |
+31.16% | 12.14B | |
-0.64% | 11.99B |
- Stock Market
- Equities
- ULTI Stock
- Company Ultimovacs ASA